Deal Library / Pharma BD Deal Intelligence

Royalty Pharma — Pharma Deals

The Pharma Closeout tracks 3 deals, $1.6B in disclosed deal value for Royalty Pharma.

Median Critic Score: 88

All 3 deals

• Royalty Pharma / Neurimmune AG (NI006 license) — 2026 · $425M
• Royalty Pharma / BeOne Medicines Ltd. — 2025 · $950M
• Royalty Pharma / Biohaven Pharmaceutical Holding Co. Ltd. (rimegepant funding) — 2019 · $200M

← Deal Library  ·  Interactive search  ·  How we score deals